Activation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells.
about
Associations between dietary intake of choline and betaine and lung cancer riskHuman breast cancer tissues contain abundant phosphatidylcholine(36∶1) with high stearoyl-CoA desaturase-1 expressionIn vivo Magnetic Resonance Metabolic and Morphofunctional Fingerprints in Experimental Models of Human Ovarian CancerCholine Metabolism Alteration: A Focus on Ovarian CancerThe human plasma lipidomeCholine metabolism-based molecular diagnosis of cancer: an updateKey Players in Choline Metabolic Reprograming in Triple-Negative Breast CancerRole of sphingomyelin synthase in controlling the antimicrobial activity of neutrophils against Cryptococcus neoformansLipin-1 regulation of phospholipid synthesis maintains endoplasmic reticulum homeostasis and is critical for triple-negative breast cancer cell survival.Choline-releasing glycerophosphodiesterase EDI3 drives tumor cell migration and metastasisA new family of choline kinase inhibitors with antiproliferative and antitumor activity derived from natural products.Phosphatidylcholine-specific phospholipase C inhibition down- regulates CXCR4 expression and interferes with proliferation, invasion and glycolysis in glioma cells.Propolis Reduces Phosphatidylcholine-Specific Phospholipase C Activity and Increases Annexin a7 Level in Oxidized-LDL-Stimulated Human Umbilical Vein Endothelial Cells.Mycobacterial heat shock protein 65 mediated metabolic shift in decidualization of human endometrial stromal cellsChanges in gene expression and cellular architecture in an ovarian cancer progression model.Molecular Effects of Doxorubicin on Choline Metabolism in Breast Cancer.Differential co-expression analysis reveals a novel prognostic gene module in ovarian cancerGlycerophosphodiester phosphodiesterase domain containing 5 (GDPD5) expression correlates with malignant choline phospholipid metabolite profiles in human breast cancerInhibition of phosphatidylcholine-specific phospholipase C results in loss of mesenchymal traits in metastatic breast cancer cells.A transcriptome analysis by lasso penalized Cox regression for pancreatic cancer survival.Reproducibility of total choline/water ratios in mouse U87MG xenograft tumors by 1H-MRS.Modulation of melanoma cell phospholipid metabolism in response to heat shock protein 90 inhibition.Combined 5-FU and ChoKα inhibitors as a new alternative therapy of colorectal cancer: evidence in human tumor-derived cell lines and mouse xenografts.Molecular and functional imaging of invasion and metastasis: windows into the metastatic cascade.Pathway-gene identification for pancreatic cancer survival via doubly regularized Cox regressionCholine metabolism in malignant transformation.Acquired resistance to EGFR tyrosine kinase inhibitors alters the metabolism of human head and neck squamous carcinoma cells and xenograft tumours.Inhibition of Phosphatidylcholine-Specific Phospholipase C Interferes with Proliferation and Survival of Tumor Initiating Cells in Squamous Cell CarcinomaGlobal metabolic profile identifies choline kinase alpha as a key regulator of glutathione-dependent antioxidant cell defense in ovarian carcinomaIn vivo detection of phospholipase C by enzyme-activated near-infrared probes.Choline kinase alpha-Putting the ChoK-hold on tumor metabolism.Elevated and secreted phospholipase A₂ activities as new potential therapeutic targets in human epithelial ovarian cancer.EDI3 links choline metabolism to integrin expression, cell adhesion and spreadingLipidomics analysis of follicular fluid by ESI-MS reveals potential biomarkers for ovarian endometriosisGlucose restriction induces cell death in parental but not in homeodomain-interacting protein kinase 2-depleted RKO colon cancer cells: molecular mechanisms and implications for tumor therapyEvaluating cell lines as tumour models by comparison of genomic profiles.Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer.Use of Plasma Metabolomics to Identify Diagnostic Biomarkers for Early Stage Epithelial Ovarian Cancer.Characterization of choline kinase in human endothelial cells.Noninvasive phosphorus magnetic resonance spectroscopic imaging predicts outcome to first-line chemotherapy in newly diagnosed patients with diffuse large B-cell lymphoma.
P2860
Q19896534-79FAD164-3940-468A-B3F3-E079158D44FDQ21090768-55535FC3-59C7-4D3F-94A1-6B911D1B1C94Q26742109-1D02EF26-C751-4BB4-B956-39E28C6A14E0Q26742116-BB3EE398-2313-46C6-BAAF-F0483A3F1597Q26830940-6BD4AA9A-3487-4B9E-B935-FDAEF7A23798Q27024079-02914259-7088-4082-B1C4-0A287AA83231Q28074613-03DE8BA5-D50B-4BB5-B11F-B1D542019EA7Q28476635-1EFB9843-286C-4E5C-AE6E-3C876DB79AF8Q30252850-41228587-2474-4B6C-A888-BD64A020CC6BQ30514230-23978DB2-3C2F-4578-9081-DB6350420C25Q30874197-EB8F5606-98B8-41A5-8A3C-C3212D1BA6B9Q33580152-0132BAD0-8FA9-4488-8764-1CDB4EE46409Q33594419-6D928C1F-D77E-4CE0-9950-E96467D332E1Q33822437-D36F6FCC-6B7B-453D-A9FD-18390CFDB5DCQ33842047-1C55DF26-75B6-4E6F-97CB-FE081FFE4F9DQ33842777-C8D7672D-A4F9-4E3F-8E27-B9FAD28182B2Q33890351-8FE62A1B-E524-4ED8-9D05-0DFE5BE1F2D9Q34020037-E6CA6D0B-20E0-4EA3-B226-FE9464AA5DF1Q34201606-B3A9A745-B3A2-44F6-99DA-E26B0308F7C2Q34238554-481F39B0-BD7F-44D5-9D66-429292E574FCQ34239921-910E9A46-A4D1-40B5-BE08-34FE654BAA0AQ34249948-CEE4CBEF-B43B-4F27-B584-3B408DF85459Q34769536-633012C1-C9EE-45A6-B44E-AEBF95AEFF07Q35064453-B51835B5-F574-409D-80E8-0E595FD7D31EQ35102086-0FFB5791-C425-48A9-9D3E-DEDBEF0348D1Q35112040-EB7D202C-D977-4FED-9978-F7C16080326FQ35275024-B29BC0B5-13F9-4F88-B24D-82001B47E56CQ35786713-53D8FDFB-055A-4A9C-B354-D6D8082BD6CCQ35793767-143E54D3-D168-4371-9019-D0959A72F08AQ35799716-E53CDECD-50DC-4EDD-AB12-F3C7D5E789C3Q35987985-A28997F9-8E92-499E-9012-301A160F10ADQ36117436-8096BB0B-4E95-4A1C-B27F-B2AB685679E7Q36124959-5A4AF0E6-4169-474E-848E-DECC90FC3484Q36378552-0CB405ED-5673-49A9-830D-DA01941B3740Q36907145-239FEF0C-669B-4C8C-8ABD-60023C3B886AQ37025950-608CD532-F0F6-4717-86B4-3EE4EC4BA7DBQ37040827-74548906-2AE3-44A6-9385-ADA1419D0347Q37068001-A91370B9-0731-496B-A231-9B8B38B7011CQ37239363-2F81EA7E-46E0-4EB4-8585-C9101AF4175EQ37260499-8F322CD3-49AF-4F41-A008-0198D9BB51FF
P2860
Activation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Activation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells.
@ast
Activation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells.
@en
type
label
Activation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells.
@ast
Activation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells.
@en
prefLabel
Activation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells.
@ast
Activation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells.
@en
P2093
P2860
P50
P1433
P1476
Activation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells.
@en
P2093
Alessandro Ricci
Elisa Venturini
Franca Podo
Kristine Glunde
Maria Elena Pisanu
Massimo Di Vito
Silvana Canevari
Zaver M Bhujwalla
P2860
P304
P356
10.1158/0008-5472.CAN-09-3833
P407
P577
2010-02-23T00:00:00Z